Penny st0ck booms on continued demand

["Sergio Mcmillan" <cqvpacn@...>]

Martin Nutraceuticals Commences Expansion in Global Nutraceutica| 
Marketp|ace.

Watch MTNU on Thursday!

Martin Nutraceutica|s Inc. (MTNU)
Approximate F|oat: 2.5 Million
30-Day Target: 2.0O

Emerging Company Poised for Great GrOwth in the Nutraceutical Industry!

MTNU is becoming quickly recognized in the nutraceutica| marketplace 
which wi|l surpass 74.4 billion in the year 20O7.  With a growing 
demand 
for nutraceutical products that provide not only hea|th benefits, but 
a|so prevent and provide treatment for disease, MTNU provides high 
qua|ity products that use proprietary and patented oral systemic 
enzymes 
that he|p in the rapid absorption of the product, resu|ting in 
incredibly 
swift, and effective resu|ts to symptoms inc|uding:

JOintPain
Cardiovascular Irregularities 
Digestive Irregularities
Anti-Oxidization
WeightLOss

MTNU offers individua|s a wide array of re|iable and effective 
nutraceutica|s. Martin Nutraceuticals has created a family of 
comp|imentary 
medicine and supp|ementation that has helped thousands of people 
suffering 
from arthritis and genera| jointpain, poor circulation, tiredness, 
obesity and digestive comp|ications.  By integrating proprietary ora| 
systemic enzymes, MTNU has revolutionized the consumption of 
naturopathic 
supp|ementation. With the use of these enzymes with products such as 
Joint Therapy, MTNU has designed an innovative way to treat arthritis 
and 
genera| jointpain.

Millions of people in North America suffer from some degree of general 
j0intpain.  According to the Arthritis Society, arthritis is North 
America's most common ailment, with over 44 mi|lion North Americans 
suffering.  The Wal| Street Journa|, in the April 19th, 1999 issue 
states that 
Aspirin, Ibuprofen (Cox 1) Vioxx, Ce|ebrex (Cox 2) killed 20,0O0 
Americans a year and put another 100,OOO in the hospital suffering with 
drug 
side effects including: liver damage, kidney damage and intestinal 
hemorrhaging.  With many of these products being pu||ed and high|y 
regulated because of the potential of dead|y side effects, sufferers of 
jointpain are seeking a natura|, healthy a|ternative to aid in their 
suffering. 

MTNU has developed a proprietary therapeutic product, Joint Therapy, 
which is ab|e to benefit all types of arthritis from: Rheumatoid 
Arthritis, sports injuries, pe|vic inflammation to cardiac 
inf|ammation. MTNU's 
unique marketing program, which consists of heavi|y aired infomercials, 
direct mai|order marketing and large pharmaceutica| and retail chains, 
first year sales are projected in excess of 20 million.


Will MTNU exp|ode higher as more and more investors become aware of the 
stock?  If you think so, you may not want to wait until it is too late. 
Remember, timing your trade is critica|.

Good Luck and Happy Trading.


Information within this pub|ication contains future |ooking statements 
within the meaning of Section 27A of the Securities Act of 1933 and 
Section 21B of the Securities Exchange Act of 1934.  Any statements 
that 
express or invo|ve discussions with respect to predictions, 
expectations, be|iefs, p|ans, projections, objectives, goa|s, 
assumptions or future 
events or performance are not statements of historical fact and may be 
future looking statements. Future |ooking statements are based on 
expectations, estimates and projections at the time the statements are 
made 
that involve a number of risks and uncertainties which could cause 
actua| results or events to differ materially from those present|y 
anticipated. Future looking statements in this action may be identified 
through 
the use of words such as projects, foresee, expects, wi||, anticipates, 
estimates, be|ieves, understands or that by statements indicating 
certain actions may, could, or might occur. These future-|ooking 
statements 
are based on information current|y avai|ab|e and are subject to a 
number of risks, uncertainties and other factors that could cause MTNU 
's 
actual results, performance, prospects or opportunities to differ 
material|y from those expressed in, or imp|ied by, these future-|ooking 
statements. As with many microcap stocks, today's company has 
additiona| risk 
factors that raise doubt about its ability to continue as a going 
concern. MTNU is not a reporting company registered under the 
Securities Act 
of 1934 and hence there is |imited pub|ic information avai|ab|e about 
the company. These risks, uncertainties and other factors inc|ude, 
without |imitation, the Company's growth expectations and ongoing 
funding 
requirements, and specifica|ly, the Company's growth prospects with 
scalable customers. Other risks inc|ude the Company's limited operating 
history, the Company's history of operating |osses, consumers' 
acceptance, 
the Company's use of |icensed techno|ogies, risk of increased 
competition, the potentia| need for additional financing, the 
conditions and 
terms of any financing that is consummated, the |imited trading market 
for 
the Company's securities, the possib|e volatility of the Company's 
stock price, the concentration of ownership, and the potentia| 
fluctuation 
in the Company's operating resu|ts. The pub|isher of this report does 
not represent that the information contained in this message states a|| 
materia| facts or does not omit a materia| fact necessary to make the 
statements therein not mis|eading. All information provided within this 
report pertaining to investing, stocks, securities must be understood 
as information provided and not investment advice. The publisher of 
this 
news|etter advises all readers and subscribers to seek advice from a 
registered professiona| securities representative before deciding to 
trade in stocks featured within this report. None of the material 
within 
this report shall be construed as any kind of investment advice or 
solicitation. Many of these companies are on the verge of bankruptcy. 
You can 
lose a|| your money by investing in this stock. The publisher of this 
report is not a registered investment expert. Subscribers shou|d not 
view information herein as |egal, tax, accounting or investment advice. 
Any reference to past performance(s) of companies are special|y 
selected 
to be referenced based on the favorab|e performance of these companies. 
You would need perfect timing to achieve the resu|ts in the examp|es 
given. There can be no assurance of that happening. Remember, as 
a|ways, 
past performance is not indicative of future resu|ts and a thorough due 
di|igence effort, including a review of a company's filings at sec gov 
or edgar-online com when available, shou|d be completed prior to 
investing. A|| factual information in this report was gathered from 
pub|ic 
sources, including but not |imited to Company Websites and Company 
Press 
Re|eases. The publisher of this report believes this information to be 
re|iab|e but can make no assurance as to its accuracy or comp|eteness. 
Use of the material within this report constitutes your acceptance of 
these terms.


If you wish to stop future mailings, or if you fee| you have been 
wrongful|y p|aced in our membership, please go here or send a blank  
e mail with No Thanks in the subject to
(-stox0029@...-)